DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Heinrich MC, Marino-Enriquez A, Presnell A et al.
Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors.
Mol Cancer Ther 2012;
11: 1770-1780
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.